These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6100146)

  • 1. Transformation of human colostrum lymphocytes with Epstein-Barr virus and the production of IgA in culture.
    Maeda-Takekoshi F; Takekoshi M; Tanaka S; Watanabe Y; Dosako S; Kikuchi E
    Tokai J Exp Clin Med; 1984 Jun; 9(2):103-8. PubMed ID: 6100146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of human colostrum lymphocytes with Epstein-Barr virus.
    Shinmoto H; Dosako S; Tanaka S
    Tokai J Exp Clin Med; 1992 Oct; 17(3-4):129-32. PubMed ID: 1338659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME; Chan MA; Sigal NH
    J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA; Miller G
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G; Blaese RM; Yarchoan R
    J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-transformation of surface IgA-positive human lymphocytes.
    Steinitz M; Klein G
    J Immunol; 1980 Jul; 125(1):194-6. PubMed ID: 6247394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution.
    Miyawaki T; Kubagawa H; Butler JL; Cooper MD
    J Immunol; 1988 Jun; 140(11):3887-92. PubMed ID: 2836502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy.
    Layward L; Allen AC; Harper SJ; Feehally J
    Exp Nephrol; 1994; 2(1):24-9. PubMed ID: 8081994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
    Stein LD; Ledgley CJ; Sigal NH
    J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular origins of human polymeric and monomeric IgA: intracellular and secreted forms of IgA.
    Moldoveanu Z; Egan ML; Mestecky J
    J Immunol; 1984 Dec; 133(6):3156-62. PubMed ID: 6092467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
    Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
    J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of breast milk of healthy and allergic mothers on in vitro stimulation of cord blood lymphocytes.
    Zizka J; Hrdý J; Lodinová-Zádníková R; Kocourková I; Novotná O; Sterzl I; Prokesová L
    Pediatr Allergy Immunol; 2007 Sep; 18(6):486-94. PubMed ID: 17651385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin-secreting cells in cord blood: effects of Epstein-Barr virus and interleukin-4.
    Gudmundsson KO; Thorsteinsson L; Gudmundsson S; Haraldsson A
    Scand J Immunol; 1999 Jul; 50(1):21-4. PubMed ID: 10404047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
    Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M; Matej H; Duś D; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protective human monoclonal IgA antibody produced in vitro: anti-pneumococcal antibody engendered by Epstein-Barr virus-immortalized cell line.
    Steinitz M; Tamir S; Ferne M; Goldfarb A
    Eur J Immunol; 1986 Feb; 16(2):187-93. PubMed ID: 3007166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.